← Leaderboards
Aaron D. Gitler
Stanford University
$25,518,377
Attributed
$31,535,030
Total exposure
17
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,725,001 · 18
By mechanism
U54$12,924,474 · 5
R35$9,718,526 · 2
R01$9,523,374 · 5
RF1$2,824,794 · 1
DP2$2,360,443 · 1
T32$1,424,028 · 1
Top collaborators
- Leonard Petrucelli8 shared
- Jin Hyung Lee6 shared
- Mercedes Prudencio6 shared
- Towfique Raj6 shared
- William W Seeley6 shared
- Nancy M Bonini5 shared
- Pietro Fratta5 shared
- Tony Wyss-Coray4 shared
Most similar at Stanford University
Same institution · by research overlap
- Pietro Fratta$0
- Garam Kim$46,752
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticNerve DegenerationNeurodegenerative DisordersProtein Tdp-43NeuronsInnovationGenesProteinsPathologyTherapeutic TargetGenetic Risk FactorMutationParkinson DiseaseInsightBrainHuman GeneticsProgramsPathway InteractionsAffectAlzheimer&AposRna-Binding ProteinsCellsLaboratoriesAlpha Synuclein
Grant awards (60)
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,572,782
U54 · FY2025 · NS · contact PI
Innovating next generation technologies to define mechanisms of neurodegenerative disease and devise therapeutic strategies$1,136,484
R35 · FY2025 · NS · contact PI
Defining modifiers and mechanisms of RAN translation$744,302
R01 · FY2025 · AG
Cryptic exon splicing mediated by TDP-43 loss of function as the underlying mechanism of pathogenesis in FTLD-TDP$740,872
U54 · FY2025 · NS · contact PI
Administrative Core$153,593
U54 · FY2025 · NS · contact PI
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$53,900
U54 · FY2025 · NS · contact PI
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,598,861
U54 · FY2024 · NS · contact PI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$1,085,210
R35 · FY2024 · NS · contact PI
Defining modifiers and mechanisms of RAN translation$771,846
R01 · FY2024 · AG
Cryptic exon splicing mediated by TDP-43 loss of function as the underlying mechanism of pathogenesis in FTLD-TDP$770,379
U54 · FY2024 · NS · contact PI
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease$601,347
R01 · FY2024 · AG
Administrative Core$153,530
U54 · FY2024 · NS · contact PI
Stanford Training Program in Aging Research$103,408
T32 · FY2024 · AG
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,597,452
U54 · FY2023 · NS · contact PI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$1,118,773
R35 · FY2023 · NS · contact PI
Cryptic exon splicing mediated by TDP-43 loss of function as the underlying mechanism of pathogenesis in FTLD-TDP$786,257
U54 · FY2023 · NS · contact PI
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease$601,347
R01 · FY2023 · AG
Stanford Training Program in Aging Research$483,724
T32 · FY2023 · AG
Administrative Core$151,993
U54 · FY2023 · NS · contact PI
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,644,973
U54 · FY2022 · NS · contact PI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$1,027,273
R35 · FY2022 · NS · contact PI
Cryptic exon splicing mediated by TDP-43 loss of function as the underlying mechanism of pathogenesis in FTLD-TDP$810,301
U54 · FY2022 · NS · contact PI
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease$601,915
R01 · FY2022 · AG
Stanford Training Program in Aging Research$388,312
T32 · FY2022 · AG
Administrative Core$155,067
U54 · FY2022 · NS · contact PI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$91,500
R35 · FY2022 · NS · contact PI
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets$1,722,003
U54 · FY2021 · NS · contact PI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$1,036,834
R35 · FY2021 · NS · contact PI
Cryptic exon splicing mediated by TDP-43 loss of function as the underlying mechanism of pathogenesis in FTLD-TDP$842,467
U54 · FY2021 · NS · contact PI
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease$604,813
R01 · FY2021 · AG
Stanford Training Program in Aging Research$448,584
T32 · FY2021 · AG
Administrative Core$170,044
U54 · FY2021 · NS · contact PI
2020 Molecular & Cellular Neurobiology Gordon Research Conference and Gordon Research Seminar$10,337
R13 · FY2021 · NS · contact PI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$1,132,610
R35 · FY2020 · NS · contact PI
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreading of neurodegenerative disease$607,625
R01 · FY2020 · AG
Defining modifiers and mechanisms of RAN translation$2,824,794
RF1 · FY2019 · AG
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$1,027,273
R35 · FY2019 · NS · contact PI
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreading of neurodegenerative disease$774,092
R56 · FY2019 · AG
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$95,776
R35 · FY2019 · NS · contact PI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$1,027,273
R35 · FY2018 · NS · contact PI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease$939,520
R35 · FY2017 · NS · contact PI
Molecular Basis of TDP-43 Proteinopathies: Disease Models and Mechanisms$351,023
R01 · FY2016 · NS · contact PI
Defining the mechanisms of dipeptide repeat protein toxicity in C9orf72 ALS/FTD$140,241
R01 · FY2016 · NS · contact PI
Defining the mechanisms of dipeptide repeat protein toxicity in C9orf72 ALS/FTD$442,988
R01 · FY2015 · NS · contact PI
Molecular Basis of TDP-43 Proteinopathies: Disease Models and Mechanisms$350,391
R01 · FY2015 · NS · contact PI
Ataxin-2 as a genetic risk factor for ALS: New insights into neurodegeneration$341,510
R01 · FY2015 · NS
RNA lariat debranching enzyme as a novel drug target$75,500
R03 · FY2015 · NS
Molecular Basis of TDP-43 Proteinopathies: Disease Models and Mechanisms$349,780
R01 · FY2014 · NS · contact PI
Ataxin-2 as a genetic risk factor for ALS: New insights into neurodegeneration$338,339
R01 · FY2014 · NS
RNA lariat debranching enzyme as a novel drug target$89,433
R03 · FY2014 · NS
Ataxin-2 as a genetic risk factor for ALS: New insights into neurodegeneration$330,028
R01 · FY2013 · NS
Molecular basis of TDP-43 proteinopathies: disease models and mechanisms$320,014
R01 · FY2013 · NS · contact PI
Ataxin-2 as a genetic risk factor for ALS: New insights into neurodegeneration$342,231
R01 · FY2012 · NS
Molecular basis of TDP-43 proteinopathies: disease models and mechanisms$331,765
R01 · FY2012 · NS · contact PI
Ataxin-2 as a genetic risk factor for ALS: New insights into neurodegeneration$342,457
R01 · FY2011 · NS
Molecular basis of TDP-43 proteinopathies: disease models and mechanisms$332,935
R01 · FY2011 · NS · contact PI
Molecular basis of TDP-43 proteinopathies: disease models and mechanisms$336,472
R01 · FY2010 · NS · contact PI
Molecular basis of TDP-43 proteinopathies: disease models and mechanisms$340,005
R01 · FY2009 · NS · contact PI
Using yeast cells to define mechanisms of human neurodegenerative diseases$1,714,396
DP2 · FY2008 · OD · contact PI
Using yeast cells to define mechanisms of human neurodegenerative diseases$646,047
DP2 · FY2008 · OD · contact PI